These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36376862)

  • 1. The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1.
    Shen W; Pu J; Zuo Z; Gu S; Sun J; Tan B; Wang L; Cheng J; Zuo Y
    Cancer Cell Int; 2022 Nov; 22(1):353. PubMed ID: 36376862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALKBH5-mediated m
    Chen S; Zhou L; Wang Y
    Cancer Cell Int; 2020; 20():34. PubMed ID: 32021563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m
    Zhang X; Wang F; Wang Z; Yang X; Yu H; Si S; Lu J; Zhou Z; Lu Q; Wang Z; Yang H
    Ann Transl Med; 2020 May; 8(10):646. PubMed ID: 32566583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALKBH5 is a prognostic factor and promotes the angiogenesis of glioblastoma.
    Fan Y; Yan D; Ma L; Liu X; Luo G; Hu Y; Kou X
    Sci Rep; 2024 Jan; 14(1):1303. PubMed ID: 38221546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALKBH5 regulates ovarian cancer growth via demethylating long noncoding RNA PVT1 in ovarian cancer.
    Li L; Chen J; Wang A; Yi K
    J Cell Mol Med; 2024 Jan; 28(2):e18066. PubMed ID: 38098223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.
    Zhao Y; Hu J; Sun X; Yang K; Yang L; Kong L; Zhang B; Li F; Li C; Shi B; Hu K; Sun A; Ge J
    Clin Transl Med; 2021 May; 11(5):e402. PubMed ID: 34047466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.
    Li W; Huang G; Wei J; Cao H; Jiang G
    Mol Cell Biochem; 2023 Apr; 478(4):729-741. PubMed ID: 36070054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALKBH5 promotes the progression of infantile hemangioma through regulating the NEAT1/miR-378b/FOSL1 axis.
    Peng K; Xia RP; Zhao F; Xiao Y; Ma TD; Li M; Feng Y; Zhou CG
    Mol Cell Biochem; 2022 May; 477(5):1527-1540. PubMed ID: 35182329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced m6A demethylase ALKBH5 promotes ovarian cancer tumorigenicity by decreasing methylation of the lncRNA RMRP.
    Lyu Y; Wang Y; Ding H; Li P
    Am J Cancer Res; 2023; 13(9):4179-4191. PubMed ID: 37818080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness
    Liu X; Wang Z; Yang Q; Hu X; Fu Q; Zhang X; Li W
    Front Oncol; 2022; 12():858694. PubMed ID: 35530319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1.
    Guo T; Liu DF; Peng SH; Xu AM
    Am J Transl Res; 2020; 12(8):4542-4549. PubMed ID: 32913527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALKBH5 Inhibited Cell Proliferation and Sensitized Bladder Cancer Cells to Cisplatin by m6A-CK2α-Mediated Glycolysis.
    Yu H; Yang X; Tang J; Si S; Zhou Z; Lu J; Han J; Yuan B; Wu Q; Lu Q; Yang H
    Mol Ther Nucleic Acids; 2021 Mar; 23():27-41. PubMed ID: 33376625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.
    Hu Y; Gong C; Li Z; Liu J; Chen Y; Huang Y; Luo Q; Wang S; Hou Y; Yang S; Xiao Y
    Mol Cancer; 2022 Feb; 21(1):34. PubMed ID: 35114989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
    Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS
    Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1.
    Zhang J; Guo S; Piao HY; Wang Y; Wu Y; Meng XY; Yang D; Zheng ZC; Zhao Y
    J Physiol Biochem; 2019 Aug; 75(3):379-389. PubMed ID: 31290116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.